Ionis Pharmaceuticals Inc (NASDAQ:IONS)
| 48.35 Delayed Data As of Nov 28 |  -1.36 / -2.74%Today’s Change | 32.69 Today|||52-Week Range 50.39 | +28.01% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 283.7M | 346.6M | 507.7M | 599.7M | |
| Cost of Goods Sold | -- | -- | -- | 1.8M | ||
| Depreciation And Amortization | 10.2M | 9.0M | 8.3M | 12.5M | ||
| Operating Expenses | Gross Income | -- | -- | -- | 585.3M | |
| General Expenses | 349.2M | 381.6M | 474.4M | 645.9M | ||
| Research And Development | 319.4M | 341.8M | 374.0M | 413.4M | ||
| Total Operating Expenses | 359.5M | 390.6M | 482.7M | 660.2M | ||
| Non-Operating Expenses | Operating Income | -75.8M | -44.0M | 24.9M | -60.6M | |
| Extraordinary Charge | 0.00 | -6.3M | -8.1M | -800.0K | ||
| Interest Expense On Debt | 36.7M | 38.8M | 44.8M | 44.8M | ||
| Other Expenses | 20.3M | 56.0K | -3.2M | -182.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -87.9M | -83.6M | -23.3M | -76.2M | |
| Income Taxes | -372.0K | -2.9M | -6.0M | -291.1M | ||
| Minority Interest | 0.00 | 0.00 | -11.3M | -58.8M | ||
| Net Income | -88.3M | -86.6M | 9.7M | 276.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 119.7M | 120.9M | 124.0M | 132.3M | |
| Shares To Calculate EPS Diluted | 119.7M | 120.9M | 126.1M | 134.1M | ||
| Earnings Per Share | EPS | -$0.74 | -$0.72 | $0.08 | $2.07 | |
| EPS Diluted | -$0.74 | -$0.72 | $0.08 | $2.07 | ||
